USSTOCK.TODAY
Weekend. Closed Log in Sign up

Zoar Ltd(ZOAR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

ZOAR
ZOAR
New
Zoar Ltd
At close Nov 20 at 4:00 PM ET (Korea 11/21 06:00)
$3.38
-2.79 ▼ -45.22%
Nov 20 at 6:01 PM ET (Korea 11/21 08:01)
$3.11
-0.27 ▼ -7.99%

Full metrics table

Index ⓘ -P/E ⓘ 16.28EPS (ttm) ⓘ 0.21Insider Own ⓘ 7.36%Shs Outstand ⓘ 8.5MPerf Week ⓘ -34.24%
Market Cap ⓘ 0.03BForward P/E ⓘ -EPS next Y ⓘ -Insider Trans ⓘ -0.14%Shs Float ⓘ 7.9MPerf Month ⓘ -11.05%
Enterprise Value ⓘ 0.03BPEG ⓘ -EPS next Q ⓘ -Inst Own ⓘ 3.58%Short Float ⓘ 0.31%Perf Quarter ⓘ -40.88%
Income ⓘ 0.00BP/S ⓘ 756.12EPS this Y ⓘ -Inst Trans ⓘ 0.29%Short Ratio ⓘ 1.4Perf Half Y ⓘ -50.75%
Sales ⓘ 0.00BP/B ⓘ 2.85EPS next 5Y ⓘ -ROA ⓘ 9.32%Short Interest ⓘ 0.02MPerf YTD ⓘ -46.96%
Book/sh ⓘ 1.18P/C ⓘ 1512.24EPS past 3/5Y ⓘ 15.09% -48.52%ROE ⓘ 371.29%52W High ⓘ -67.73% ($10.47)Perf Year ⓘ -40.48%
Cash/sh ⓘ 0P/FCF ⓘ 252.04Sales past 3/5Y ⓘ -ROIC ⓘ 15.95%52W Low ⓘ 39.09% ($2.43)Perf 3Y ⓘ -
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ 100.44%Gross Margin ⓘ -4026.32%Volatility(W/M) ⓘ 14.08% 15.21%Perf 5Y ⓘ -
Dividend TTM ⓘ -EV/Sales ⓘ 836.87Sales Y/Y TTM ⓘ 52%Oper. Margin ⓘ -12623.68%ATR (14) ⓘ 0.8Perf 10Y ⓘ -
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 0.02EPS Q/Q ⓘ 95.04%Profit Margin ⓘ 4247.37%RSI (14) ⓘ 42.1Recom ⓘ -
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 0.04Sales Q/Q ⓘ 16.67%SMA20 ⓘ -20.09% ($4.23)Beta ⓘ 1.38Target Price ⓘ -
Payout ⓘ -Debt/Eq ⓘ 0Earnings ⓘ -SMA50 ⓘ -29.24% ($4.78)Rel Volume ⓘ 1.25Prev Close ⓘ $6.17
Employees ⓘ 8LT Debt/Eq ⓘ 0EPS/Sales Surpr. ⓘ -SMA200 ⓘ -45.14% ($6.16)Avg Volume(3M) ⓘ 0.02MPrice ⓘ $3.38
IPO ⓘ 2024/9/16Option/Short ⓘ No/YesTrades ⓘ 331Volume ⓘ 21,986Change ⓘ -45.22%
Company
ZOAR ZOARZoar Ltd | AMEX | Biotechnology

💊 A pharmaceutical company that develops and produces drug ingredients and intermediates to supply global pharmaceutical companies. Established in 2012, it handles ingredients for various therapeutic areas, including oncology, anticoagulation, antimalarial, antiviral, bronchodilation, and respiratory diseases, and also provides contract development and manufacturing services for complex ingredients. It has expanded its access to capital markets through listing on the U.S. stock exchange.

Quote

Over the past 1 year, on the lower side

68% below its 1-year high.

Now $3.38
52w low$2.4352w high$10.47
52W Range12%
Volume ⓘ 21,986

Traded about as much as usual. That is 125% of its average volume.

D
Overall · many cautions
We judged 4 of the 8 questions below. 2 need caution.
No data for growth, earnings, outlook, dividends, or not applicable.
Peer comparison Biotechnology

It ranks #435 of 598 in the industry

Based on market cap of $30M.

FAQ

FAQ

ZOAR belongs to the Healthcare sector and operates in the Biotechnology industry.

The market cap of ZOAR is approximately $30M, ranking 4,979 within its sector.

ZOAR has a P/E ratio of approximately 16.3x, which can be used to assess its valuation relative to the Healthcare sector average.

ZOAR has recorded a 52-week high of $10.47 and a low of $2.43.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels